Prevalence and Prognostic Role of Triple-Negative Breast Cancer by Race: A Surveillance Study

Clinical Breast Cancer - United States
doi 10.1016/j.clbc.2011.04.004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Prognostic Role of Family History in Patients With Triple Negative Breast Cancer

Turk Onkoloji Dergisi
Oncology
2020English

TLR5: A Prognostic and Monitoring Indicator for Triple-Negative Breast Cancer

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2019English

Exploring Specific Prognostic Biomarkers in Triple-Negative Breast Cancer

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2019English

Role of Immunotherapy in Triple-Negative Breast Cancer

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2020English

Identification of New Prognostic Biomarkers for Triple Negative Breast Cancer

English

Prognostic Role of GPER/Ezrin in Triple Negative Breast Cancer Is Associated With Menopausal Status

Endocrine Connections
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Neutrophil:Lymphocyte Ratios Have Prognostic Value in Triple-Negative Breast Cancer

Journal of Nihon University Medical Association
2017English

Triple-Negative Breast Cancer

2018English

Molecular Subtypes of Triple-Negative Breast Cancer in Women of Different Race and Ethnicity

Oncotarget
Oncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy